SILO
NASDAQ
$4.70
SILO Pharma Inc (SILO)
Silo Pharma Inc. is a pioneering biopharmaceutical company dedicated to innovating therapeutics by integrating traditional treatment approaches with psychedelic research, focusing on mental health disorders and rare diseases. Utilizing its proprietary drug delivery technologies and forming strategic alliances, Silo aims to ensure the responsible clinical application of psychedelics within a regulatory framework. With a promising pipeline of candidates addressing significant unmet medical needs, Silo Pharma is well-positioned to capitalize on the growing interest in mental health therapeutics, offering potential value creation for investors in this dynamic sector.
Sector:
Healthcare
Industry:
Biotechnology
Target: $10 (+112.77%)
Market Cap
$5.29M
FCF 5Y CAGR
+23.26%
Free Cash Flow Yield
-72.67%
Beta (5Y)
1.23
Price Chart
Valuation
Market Cap$5.29M
P/S76.31
P/B1.02
Profitability
Total Revenue (TTM)$72K
Gross Profit (TTM)$8.58K
EBITDA-$4.80M
Operating Margin-8846%
EPS-$6.19
Financial Health
Free Cash Flow Yield-72.67%
Growth & Risk
EPS 5Y CAGR-28.50%
Revenue 5Y CAGR-3.92%
FCF 5Y CAGR+23.26%
Beta (5Y)1.23
Sharpe Ratio-0.09